Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ok I would like to know how the float would be smaller when they are printing new shares to sell them. Pure genius
They have a $100 million in the bank currently whats the rush with more dilution? Not going broke anytime soon. My guess is they want to cash in before something bad happens.
I'm just saying it hasn't worked that way in the past, and if a company were to ever give us a buyout offer, each common shareholder will get less because of Dans continuous dilution.
You do understand if they sell stock to another company or sell stock to the general public it dilutes your current holdings?
So your good with a another 50% dilution with no contols? I'm also sure he could get some more shares authorized, common shareholders here will give him anything he wants.
I remember everyone pounding the table when these awesome deals were made Global BioPharma, Biocon, Aratana. Can someone tell me where the fist dime was made with these world shattering collaborations? Looks like they were all scams to me
He took the last shelf from $200 million to $58 million in near record time. The million dollar bonuses that are being offered to new execs will consume the new shelf very rapidly. When there are 80 million shares outstanding don't come crying to me, because it is going to happen.
Not a problem for management to dilute the common shareholder to their knees, they will just give themselves more options and increase their pay to make up for the lower share price. Just look to Dans pay increase last year up almost 70% year over year
Yep and they still have a much larger market cap than ADXS with stolen technology.
Come Monday we will see what investors think about taking the current shelf at $58 million, back to $250 million that the dilution king will use up quickly will do to the share price. Taking 6 months to dose the first patient is not a good sign either. Too bad we don't have Aduro's management.
Lets put it this way, if there were any buyers at all HFT would not work and it would actually propel the share price to the upside. I remember just a short time ago when we ran to $30 and people believed in Dan and the science. Investors still believe in the science but Dan has screwed the deal up so badly that most are losing faith daily. This latest shelf offering could double the outstanding shares if it used when the stock is in the $6 or $7's. Everything points to fact that we are headed back to the $6's
Dan runs this business as if it was his own and there are no shareholders. He needed the new shelf for his new hires, and the options that they will get for signing onto this train wreck. Who gives themselves a 70% pay increase year over year. This is criminal.
Exactly if you think he left on his own, I have some ocean front property in Nevada to sell you.
I would say good luck on Monday when investors have an opportunity to digest this huge shelf that dilution Dan will run thru in no time at all. The last $200 million shelf was down to
$58 million. At $8 a share that's a additional 31 million shares. Almost a 100% dilution.
It couldn't have been me.
Maybe he will get us into some more profitable deals like the Global BioPharma, Biocon, Aratana deals. After those deals I cant figure out how were not worth 5 billion.
It is very easy to have a simple poison pill amendment to be approved by the BOD and you don't have to pay registration fees, but this wouldn't give the dilution king the availability to 250 million to spend as he wishes and dilute the common shareholder again to their knees
There are much easier and cheaper ways to stop an unwanted takeover. Dan used up almost 75% of the last shelf, don't think he wont use this shelf for whatever he wants. When this shelf is done share count will be up to 60 or 70 million.
Anybody who thought that ADXS had any kind of deal in the works to sell the company can take yesterdays huge shelf offering as a sign its not going to happen.
Dr Dilution, does he really deserve almost a 70% pay increase since the stock has fallen from $16 to the $8's. I do think the huge shelf that was introduced yesterday will be good for buyers who want to buy really cheap shares.
Yea if they had ADXS management they would have been out of business by now.
I wouldn't be a buyer above $6. Any buyout now would probably bring $10 at the most
$.40 cents off high of day and falling, must be a big deal pending for Monday? LMAO
Right as usual, welcome to the $8's
Every spike sold into, as hard as they want this to stay above $9, just too many investors wanting out
Market screaming higher, ADXS about to go red for the day. Back to the $8's
Global BioPharma, Biocon, Aratana I wonder who made money on these deals?
Global BioPharma, Biocon, Aratana Who is responsible for these 3 great collaborative deals that have all gone down the toilet? Yep Mr Dilution
I thought October was going to be our month, and then it was January, and now its two years out before any news. Should return back to the $6's until then
I would wait a while, its going to get a lot cheaper.
Your talking about a ceo who's middle name is dilution. Every deal that has been done so far has been a major screw up with no results or pay back to the company. With such a valuable IP its amazing that market cap less cash is well below $300 million. There are complete fraudulent companies out there that have 5 times the market cap. Don't worry for Dan he will stay supplied in more free shares and a hefty salary. Those 300,000 in shares are nothing compared to milking this company for the next 10 years.
Until Dan is removed, this stock will be stuck here.
You know he will, he has no interest in shareholder value, wall street recognizes this and has no interest in this stock. Why else with a P3 study in place would the market cap be under 300 million after cash.
When posters start pumping cancer cures from a penny start up marijuana stock, we may have peaked. Psoriasis cream possible but it takes billions and decades to come up for cures for multiple myeloma.
HIRU just keeps on cranking upward, you should learn not make stupid predictions.
Got to love the low volume move upward. Once volume comes in we go vertical. Go HIRU
skull and crossbones go away, PR starts, dispensaries info gets out, HIRU goes thru the roof. MJ going to be huge.......
Just the beginning here, waiting for fireworks to start
HIRU best of breed MJ stock, get ready for the climb up. Big things comong
Who would sell now, with cross bones coming down and website coming live. This is best of breed MJ company, going to rock